#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Validation of the Czech Version of the Symptoms in Persons at Risk of Rheumatoid Arthritis (SPARRA) Questionnaire


Authors: N. Růžičková 1,2;  K. Prajzlerová 1;  H. Šmucrová 1;  B. Heřmánková 3;  M. Tomčík 1,2;  J. Vencovský 1,2;  L. Šenolt 1,2;  M. Filková 1,2
Authors‘ workplace: Revmatologický ústav Praha 1;  Revmatologická klinika 1. LF UK, Praha 2;  Fakulta tělesné výchovy a sportu, Katedra fyzioterapie UK, Praha 3
Published in: Čes. Revmatol., 31, 2023, No. 1, p. 8-13.
Category: Original article

Overview

Růžičková N, Prajzlerová K, Šmucrová H, Heřmánková B, Tomčík M, Vencovský J, Šenolt L, Filková M. Validation of the Czech Version of the Symptoms in Persons at Risk of Rheumatoid Arthritis (SPARRA) Questionnaire

Clinically manifest rheumatoid arthritis (RA) is preceded by the pre-clinical phase, when interactions between genetic and environmental risk factors take place leading to autoantibodies production, such as rheumatoid factor and antibodies against citrullinated proteins. The at-risk individuals may also experience a wide spectrum of symptoms. The Symptoms in Persons at Risk of Rheumatoid Arthritis (SPARRA) Questionnaire was created to monitor these symptoms.

The goal of this work was to validate the Czech version of the SPARRA questionnaire. The original version was translated from English to the Czech language by two independent bilingual translators, then consensually synthesized and discussed by the expert panel. The synthesized version was subsequently back-translated by two blinded translators. This version was compared to the original version, and differences were discussed and implemented in the pre-final version, which was presented to the individuals at-risk of RA to assess the clarity, and then the final version was created. The validated Czech version of the SPARRA questionnaire is created primarily for research purposes aiming for future use in clinical practice to predict RA development.

Keywords:

questionnaire – Arthralgia – rheumatoid arthritis – validation – symptom


Sources
  1. Petrovska N, Prajzlerova K, Vencovsky J, Senolt L, Filkova M. The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis. Autoimmun Rev 2021; 20 : 102797.
  2. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50 : 380–386.
  1. van Steenbergen HW, van Nies JA, Huizinga TW, Bloem JL, Reijnierse M, van der Helm-van Mil AH. Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI. Ann Rheum Dis 2015; 74 : 1225–1232.
  2. Gerlag DM, Raza K, van Baarsen LG, Brouwer E, Buckley CD, et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis 2012; 71 : 638–641.
  3. van Steenbergen HW, Aletaha D, Beaart-van de Voorde LJ, Brouwer E, Codreanu C, et al. EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis. Ann Rheum Dis 2017; 76 : 491–496.
  4. Burgers LE, Siljehult F, Ten Brinck RM, van Steenbergen HW, Landewe RBM, et al. Validation of the EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis. Rheumatology (Oxford) 2017; 56 : 2123–2128.
  5. Stack RJ, van Tuyl LH, Sloots M, van de Stadt LA, Hoogland W, et al. Symptom complexes in patients with seropositive arthralgia and in patients newly diagnosed with rheumatoid arthritis: a qualitative exploration of symptom development. Rheumatology (Oxford) 2014; 53 : 1646–1653.
  6. van Beers-Tas MH, Ter Wee MM, van Tuyl LH, Maat B, Hoogland W, et al. Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project. RMD Open 2018; 4: e000641.
  7. Bell MJ, Tavares R, Guillemin F, Bykerk VP, Tugwell P, Wells GA. Development of a self-administered early inflammatory arthritis detection tool. BMC Musculoskelet Disord 2010; 11 : 50.
  8. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000; 25 : 3186–3191.
Labels
Dermatology & STDs Paediatric rheumatology Rheumatology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#